The market is segmented based on Segmentation, By Production Methods (In Vivo, In Vitro), Source (Murine, Chimeric, Humanized, Human, Others), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Others), Route of Administration (Intravenous, Subcutaneous, Intravitreal, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032
.
The Global Monoclonal Antibodies Market size was valued at USD 263.22 USD Billion in 2024.
The Global Monoclonal Antibodies Market is projected to grow at a CAGR of 13.4% during the forecast period of 2025 to 2032.
The major players operating in the market include Pfizer Inc. , GlaxoSmithKline plc , Novartis AG , Mylan N.V. , Teva Pharmaceutical Industries Ltd., Sanofi , F. Hoffmann-La Roche Ltd. , Zydus Cadila , Lupin , Amneal Pharmaceuticals LLC. , Regeneron Pharmaceuticals Inc. , Biogen , Eli Lilly and Company , AbbVie Inc. , Eisai Co.Ltd. ,Amgen Inc. , Bayer AG , Bristol-Myers Squibb Company , AstraZeneca , Johnson &, Johnson Private Limited .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.